Here are some key ways to determine if your vaginal discharge is normal
or if you have cause for concern:
Normal
Cause for concern
Colour
Clear or whitish discharge (may be Yellow or greenish discharge, or
yellowish when dried)
discharge that suddenly
changes color
Scent
Mild scent or none at all
A strong, foul, sometimes
"fishy" odor, or a sudden
change in odor
Texture
Can vary from "paste" like and
Clumpy or lumpy discharge,
somewhat sticky to clear and
with "cottage cheese" like
stretchy, depending on where you
texture
are in your cycle and whether you
are aroused
Volume
Can vary from very little to quite a Sudden changes in volume,
Risk factors
Clinical Presentation
Contraceptive practices
(e.g., birth control pills
and vaginal spermicides,
which influence vaginal
pH)
Use of systemic
steroids, which influence
the immune system
Use of antibiotics, which
alters the microbiology of
the vagina; 25% to 70% of
women report yeast
infections after antibiotic
use. Any antibiotic,
particularly a broadspectrum agent, may play
a causative role.
Tight clothing, panty
hose, and bathing suits
(yeast thrives in a dark,
warm, moist environment)
Undiagnosed or
uncontrolled diabetes
mellitus
Diagnosis
Diagnosis is made by history,
physical examination, and
microscopic examination of the
vaginal discharge in saline and 10%
KOH.
CANDIDAL VAGINITIS
Treatment
Many agents are available for the
treatment of vulvovaginal
candidiasis. These include topical
agents, which may be available over
the counter (OTC) or by prescription,
and oral agents, which are available
by prescription only.
1. Antifungal intravaginal agents
are administered as suppositories or
creams. These drugs are available in
three regimens: a single dose, 3-day
course, or 7-day course. Agents
include butoconazole, clotrimazole,
miconazole, tioconazole, and
terconazole. OTC regimens should
be used only by women who have
been diagnosed with a yeast
2. Oral Agents:
Ketoconazole,
Fluconazole
Fluconazole is available as a
single-dose (150 mg)
treatment for uncomplicated
vaginal candidiasis.
-Ketoconazole is used
effectively for the treatment of
chronic and recurrent
candidiasis; a 5% incidence of
hepatotoxicity limits more
widespread use. The dosing
schedule is 200 mg twice a
day for 5 days, then 100 to
200 mg daily for 6 months
3. Boric acid capsules
TRICHOMONAS VAGINALIS
Trichomonas vaginalis vaginitis (trichomoniasis) is the third most common vaginitis, accounting for 25% of cases.
Etiology
trichomonad can be recovered from 70% to 80% of the
This parasite is usually a marker of high-risk sexual
male partners of the infected patient; therefore,
behavior, and co-infection with other sexually
Trichomonas vaginitis is an STD.
transmitted pathogens is common, especially Neisseria
#This infection is the most prevalent nonviral STD in the
gonorrhoeae. Trichomonas vaginalis has predilection for
United States (Van der Pol, 2005, 2007). Unlike other STDs,
squamous epithelium, and lesions may increase
its incidence appears to increase with age in some studies.
accessibility to other sexually transmitted species.
Trichomoniasis is more commonly diagnosed in women
Vertical transmission during birth is possible and may
because most men are asymptomatic. However, up to 70
persist for a year.
percent of male partners of women with vaginal
trichomoniasis will have trichomonads in their urinary tract.
TRICHOMONAS VAGINALIS
Clinical presentation
Trichomonas vaginitis is a multifocal infection involving
the vaginal epithelium, Skene glands, Bartholin glands,
and urethra.
No symptoms may be noted in up to one-half of women
with trichomoniasis. However, in those with complaints,
vaginal discharge is typically described as foul, thin, and
yellow or green. Additionally, dysuria, dyspareunia, vulvar
pruritus, and pain may be noted. At times,
symptomatology and physical findings are identical to
Diagnosis
Incubation with T vaginalis requires 3 days to 4 weeks, and
the vagina, urethra, endocervix, and bladder can be
infected, such colonization may persist for months or
years in some women.
With trichomoniasis, the vulva may be erythematous,
edematous, and excoriated. The vagina contains the
above-described discharge, and subepithelial hemorrhages
or "strawberry spots" may be seen on the vagina and
cervix. Trichomoniasis is typically diagnosed by
Laboratory tests
1-The vaginal pH is usually between 5.0 and 7.0.
2-Saline wet mount of the vaginal discharge reveals
numerous leukocytes and the highly motile, flagellated
trichomonads (as many as 75% of cases).
3-Cultures are not usually necessary to make the diagnosis.
They should be obtained when the diagnosis is suspected but
cannot be confirmed by wet mount examination.
4-Pap smears may be positive in as many as 65% of cases.
Positive Pap smears should be confirmed by wet mount
examination because of the high false-positive rate.
TRICHOMONAS VAGINALIS
Treatment
Because Trichomonas is sexually transmitted, both partners require therapy; 25% of women will be reinfected if their
partner does not receive treatment.
A-Vaginal therapy alone is ineffective because of the multiple sites of infection, and systemic agents are necessary.
B-If both partners are treated simultaneously, cure rates of 90% are achieved with treatment with metronidazole. Patients
should be warned that a disulfiram-like reaction may occur and that they should abstain from alcohol use during treatment.
1-The preferred regimen is 2g in one dose because of ease of compliance. As many as 10% of patients may experience
vomiting.
2-An alternative regimen is 500 mg twice daily for 7 days.
C-Resistant cases may require treatment with intravenous metronidazole. Because resistance is rare, other causes, such as
noncompliance of the patient or partner, should be considered.
D-Metronidazole is contraindicated for use during the first trimester of pregnancy. After this time, it can be used to treat
Trichomonas infections.
E-Infected patients should be screened for other STDs.
BACTERIAL VAGINOSIS
Bacterial vaginosis is the
Etiology
Risk factors
Bacterial vaginosis is a
This condition is not considered by the Centers for
most common vaginal
infection in the United States
polymicrobial clinical syndrome
Disease Control and Prevention (CDC) consensus
today. In the past, bacterial
caused by an overgrowth of a
group to be a sexually transmitted disease (STD),
vaginitis was known as
variety of bacterial species,
and it is seen in women without previous sexual
nonspecific vaginitis and
particularly anaerobes, often
experience. Many risk factors, however, are
Gardnerella vaginitis.
found normally in the vagina.
associated with sexual activity, and an increased
Organisms most often involved
risk of acquiring STDs has been reported in
include Bacteroides,
affected women
Peptostreptococcus, Gardnerella
1-Oral sex
vaginalis, and Mycoplasma
2-Douching
hominis.
3-Black race
The anaerobic bacteria produce
4-Cigarette smoking
enzymes that break down
5-Sex during menses
peptides to amino acids and
6-Intrauterine device
amines, resulting in compounds
7-Early age of sexual intercourse
BACTERIAL VAGINOSIS
Clinical presentation
Fifty percent of women
with bacterial vaginosis
are asymptomatic.
In symptomatic patients,
the most common
presentation is a
malodorous, gray
discharge.
Treatment
Diagnosis
Three of the following four criteria must be present:
A-The vaginal pH is generally between 5.0 and 5.5.
B-Wet mount preparations with saline reveal a CLUE CELL background with minimal or no
leukocytes, an abundance of bacteria, and the characteristic clue cells. The clue cells are
squamous cells in which coccobacillary bacteria have obscured the sharp borders and
cytoplasm.
C-Application of 10% KOH to the wet mount specimen produces a fishy odor, indicating a
positive WHIFF test.
D-A gray, homogenous, malodorous discharge is present
Therapy is based on the use of agents with anaerobic activity and involves both topical and systemic agents. The
combination appears to be 90% effective
A-Vaginal preparations:
1-Intravaginal 2% clindamycin cream is used at bedtime for 7 days.
2-Intravaginal metronidazole is applied once a day for 5 days.
B-Oral regimens:
1-Metronidazole may be administered two ways: 500 mg twice daily for 7 days or a single, 2-g dose.
2-Clindamycin, 300 mg twice daily for 7 days (may be associated with diarrhea, especially Clostridium difficile)
C-Sexual partners should be treated in cases of repeated episodes of bacterial vaginosis. Routine treatment of
partners has not been shown to improve cure rates or lower reinfection rates.
D-Treatment during pregnancy is critical; data suggest an association of adverse maternal and fetal outcomes
with bacterial vaginosis.
1-Clindamycin may be used throughout pregnancy.
2-Metronidazole may be used after the first trimester.
E-Patients with recurrences should be screened for STDs
PREVENTION